Boehringer Ingelheim and Carelon Research have conducted a validation study of the Klinrisk model, a …
Bayer Launches Kerendia™ (finerenone), an Innovative Medicine to Slow Down Progression of Chronic Kidney Disease in Patients with Diabetes
Bayer today announced the launch of Finerenone under the brand name KerendiaTM in India. Finerenone …
